Skip to content

Clinical application of a disposable endovenous closed lens cleaning puncture device in video-assisted thoracoscopic surgery: a prospective randomized controlled trial

Clinical application of a disposable endovenous closed lens cleaning puncture device in video-assisted thoracoscopic surgery: a prospective randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101277
Enrollment
Unknown
Registered
2025-04-23
Start date
2025-05-06
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

Disposable endoscopic closed-lens cleaning trocar group:The research subjects underwent thoracic surgery during which disposable endoscopic closed-lens cleaning trocars were used.
Conventional trocar group:The research subjects underwent thoracic surgery by using conventional trocar

Sponsors

the Affiliated Hospital of Qingdao University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Voluntary participation and signing of the informed consent form; 2. Age 18 to 80 years old, gender unrestricted; 3. American Society of Anesthesiologists (ASA) classification I-III; 4. Patients scheduled to undergo video-assisted thoracoscopic surgery.

Exclusion criteria

Exclusion criteria: 1. Patients who refuse surgery and/or anesthesia plans; 2. Patients with any severe or uncontrollable systemic diseases, such as: 1) Major and symptomatic severe arrhythmias, conduction abnormalities or morphological abnormalities on resting electrocardiogram that are difficult to control, such as second-degree or higher atrioventricular block, ventricular arrhythmias or atrial fibrillation; 2) Unstable angina pectoris, congestive heart failure, chronic heart failure with New York Heart Association (NYHA) classification > grade 2; 3) Any arterial thrombosis, embolism or ischemia within 6 months before enrollment in the treatment, such as myocardial infarction, cerebrovascular accident or transient ischemic attack, etc.; 4) A history of non-infectious pneumonia requiring glucocorticoid treatment within 1 year before the first administration, or current clinical active interstitial lung disease; 5) Active pulmonary tuberculosis; 6) Active or uncontrolled infections requiring systemic treatment; 7) Active diverticulitis, abdominal abscess, gastrointestinal obstruction; 8) Liver diseases such as liver cirrhosis, decompensated liver disease, acute or chronic active hepatitis; 9) Urine routine test shows urine protein =++, and confirmed 24-hour urine protein quantification > 1.0 g; 10) Patients with mental disorders and inability to cooperate with treatment; 3. Phrenic nerve palsy on the non-surgical side; 4. Medical history or evidence of disease, treatment or laboratory abnormalities that may interfere with the results of the trial, prevent the participant from participating in the study fully, or other conditions considered by the investigator to be unsuitable for enrollment.

Design outcomes

Primary

MeasureTime frame
Number of lens cleanings;Lens cleaning time;

Secondary

MeasureTime frame
Single lens cleaning time;Re-cleaning rate of lens;Operation time;Anesthesia time;Postoperative pulmonary complications;The percentage of neutrophilic granulocyte,IL-6,IFN,TNF;

Countries

China

Contacts

Public ContactWenjie Jiao

the Affiliated Hospital of Qingdao University

Jiaowenjie@163.com+86 186 6180 6899

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026